305 related articles for article (PubMed ID: 33643820)
1. SUV39H1 deficiency suppresses clear cell renal cell carcinoma growth by inducing ferroptosis.
Wang J; Yin X; He W; Xue W; Zhang J; Huang Y
Acta Pharm Sin B; 2021 Feb; 11(2):406-419. PubMed ID: 33643820
[TBL] [Abstract][Full Text] [Related]
2. Knockdown of SETD2 promotes erastin-induced ferroptosis in ccRCC.
Xue W; Jian W; Meng Y; Wang T; Cai L; Yu Y; Yu Y; Xia Z; Zhang C
Cell Death Dis; 2023 Aug; 14(8):539. PubMed ID: 37604811
[TBL] [Abstract][Full Text] [Related]
3. Identification and validation of novel prognostic markers in Renal Cell Carcinoma.
Rabjerg M
Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975890
[TBL] [Abstract][Full Text] [Related]
4. PRMT1 is a novel molecular therapeutic target for clear cell renal cell carcinoma.
Wang J; Wang C; Xu P; Li X; Lu Y; Jin D; Yin X; Jiang H; Huang J; Xiong H; Ye F; Jin J; Chen Y; Xie Y; Chen Z; Ding H; Zhang H; Liu R; Jiang H; Chen K; Yao Z; Luo C; Huang Y; Zhang Y; Zhang J
Theranostics; 2021; 11(11):5387-5403. PubMed ID: 33859753
[No Abstract] [Full Text] [Related]
5. Histone lysine methyltransferase SUV39H1 is a potent target for epigenetic therapy of hepatocellular carcinoma.
Chiba T; Saito T; Yuki K; Zen Y; Koide S; Kanogawa N; Motoyama T; Ogasawara S; Suzuki E; Ooka Y; Tawada A; Otsuka M; Miyazaki M; Iwama A; Yokosuka O
Int J Cancer; 2015 Jan; 136(2):289-98. PubMed ID: 24844570
[TBL] [Abstract][Full Text] [Related]
6. MITD1 Deficiency Suppresses Clear Cell Renal Cell Carcinoma Growth and Migration by Inducing Ferroptosis through the TAZ/SLC7A11 Pathway.
Zhang Y; Li Y; Qiu Q; Chen Z; Du Y; Liu X
Oxid Med Cell Longev; 2022; 2022():7560569. PubMed ID: 36046690
[TBL] [Abstract][Full Text] [Related]
7. HO-1 Contributes to Luteolin-Triggered Ferroptosis in Clear Cell Renal Cell Carcinoma via Increasing the Labile Iron Pool and Promoting Lipid Peroxidation.
Han S; Lin F; Qi Y; Liu C; Zhou L; Xia Y; Chen K; Xing J; Liu Z; Yu W; Zhang Y; Zhou X; Rao T; Cheng F
Oxid Med Cell Longev; 2022; 2022():3846217. PubMed ID: 35656025
[TBL] [Abstract][Full Text] [Related]
8. Histone lysine methyltransferase, suppressor of variegation 3-9 homolog 1, promotes hepatocellular carcinoma progression and is negatively regulated by microRNA-125b.
Fan DN; Tsang FH; Tam AH; Au SL; Wong CC; Wei L; Lee JM; He X; Ng IO; Wong CM
Hepatology; 2013 Feb; 57(2):637-47. PubMed ID: 22991213
[TBL] [Abstract][Full Text] [Related]
9. LSD1 inhibition suppresses the growth of clear cell renal cell carcinoma
Zhu L; Wang J; Kong W; Huang J; Dong B; Huang Y; Xue W; Zhang J
Acta Pharm Sin B; 2019 Mar; 9(2):324-334. PubMed ID: 30972280
[TBL] [Abstract][Full Text] [Related]
10. Upregulation of Metallothionein 1 G (MT1G) Negatively Regulates Ferroptosis in Clear Cell Renal Cell Carcinoma by Reducing Glutathione Consumption.
Zhang W; Luo M; Xiong B; Liu X
J Oncol; 2022; 2022():4000617. PubMed ID: 36204178
[TBL] [Abstract][Full Text] [Related]
11. SUV39H1 regulates corneal epithelial wound healing via H3K9me3-mediated repression of p27.
Yang S; Chen W; Jin S; Luo G; Jing X; Liu Q; Reinach PS; Qu J; Yan D
Eye Vis (Lond); 2022 Feb; 9(1):4. PubMed ID: 35101125
[TBL] [Abstract][Full Text] [Related]
12. Ferroptosis-Related Gene Signature Accurately Predicts Survival Outcomes in Patients With Clear-Cell Renal Cell Carcinoma.
Chang K; Yuan C; Liu X
Front Oncol; 2021; 11():649347. PubMed ID: 33996565
[TBL] [Abstract][Full Text] [Related]
13. Deficiency of the X-inactivation escaping gene
Zheng Q; Li P; Zhou X; Qiang Y; Fan J; Lin Y; Chen Y; Guo J; Wang F; Xue H; Xiong J; Li F
Theranostics; 2021; 11(18):8674-8691. PubMed ID: 34522206
[No Abstract] [Full Text] [Related]
14. PHF6 functions as a tumor suppressor by recruiting methyltransferase SUV39H1 to nucleolar region and offers a novel therapeutic target for PHF6-muntant leukemia.
Tsai HI; Wu Y; Huang R; Su D; Wu Y; Liu X; Wang L; Xu Z; Pang Y; Sun C; He C; Shu F; Zhu H; Wang D; Cheng F; Huang L; Chen H
Acta Pharm Sin B; 2022 Apr; 12(4):1913-1927. PubMed ID: 35847518
[TBL] [Abstract][Full Text] [Related]
15. DPP9 Stabilizes NRF2 to Suppress Ferroptosis and Induce Sorafenib Resistance in Clear Cell Renal Cell Carcinoma.
Chang K; Chen Y; Zhang X; Zhang W; Xu N; Zeng B; Wang Y; Feng T; Dai B; Xu F; Ye D; Wang C
Cancer Res; 2023 Dec; 83(23):3940-3955. PubMed ID: 37713596
[TBL] [Abstract][Full Text] [Related]
16. Prediction of overall survival based upon a new ferroptosis-related gene signature in patients with clear cell renal cell carcinoma.
Sun Z; Li T; Xiao C; Zou S; Zhang M; Zhang Q; Wang Z; Zhan H; Wang H
World J Surg Oncol; 2022 Apr; 20(1):120. PubMed ID: 35422048
[TBL] [Abstract][Full Text] [Related]
17. Pro-Angiogenic and Pro-Inflammatory Regulation by lncRNA MCM3AP-AS1-Mediated Upregulation of DPP4 in Clear Cell Renal Cell Carcinoma.
Qiu L; Ma Y; Yang Y; Ren X; Wang D; Jia X
Front Oncol; 2020; 10():705. PubMed ID: 32714856
[TBL] [Abstract][Full Text] [Related]
18. Integration of intratumoral RASSF10 expression and tumor-associated macrophages into the established clinical indicators better predicts the prognosis of clear cell renal cell carcinoma patients.
Wang C; Hong T; Wang Y; Gan S; Wang Q; Li J; Zuo L; Cui X
Oncoimmunology; 2020; 9(1):1736793. PubMed ID: 32313718
[TBL] [Abstract][Full Text] [Related]
19. Gliotoxin Induced Ferroptosis by Downregulating SUV39H1 Expression in Esophageal Cancer Cells.
Zhang S; Guo J; Zhang H; Tong L; Zhang L
Recent Pat Anticancer Drug Discov; 2023; 18(3):397-407. PubMed ID: 36065932
[TBL] [Abstract][Full Text] [Related]
20. ACSL3 regulates lipid droplet biogenesis and ferroptosis sensitivity in clear cell renal cell carcinoma.
Klasson TD; LaGory EL; Zhao H; Huynh SK; Papandreou I; Moon EJ; Giaccia AJ
Cancer Metab; 2022 Oct; 10(1):14. PubMed ID: 36192773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
